))
CARDIOVASCULAR: Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI
Archived series ("Inactive feed" status)
When?
This feed was archived on June 29, 2019 01:11 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 151341638 series 1024717
Content provided by Audio Medica. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audio Medica or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Audio Journal of Cardiovascular Medicine, November 5th, 2007 Reporting from: American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI LAURA MAURI, Brigham and Woman’s Hospital, Boston Massachusetts COMMENT: RAYMOND GIBBONS, Mayo Clinic, Rochester, Minnesota REFERENCE: Late Breaking Special Session, AHA 2007 The largest study to date looking at long-term outcomes of bare metal stents as compared with drug eluting stents in patients who have undergone PCI was presented to the American Heart Association annual meeting. There was no increased mortality for patients who received drug eluting stents in a Massachussets based population. Sarah Maxwell spoke with investigator to Laura Mauri at the Orlando meeting.
…
continue reading
106 episodes
Share
